Clinical Trial Update: Extension Study to Assess Batoclimab in Participants With Thyroid Eye Disease [Phase 3]

View source ↗

Summary

An extension-phase 3 study of batoclimab for Thyroid Eye Disease is listed as active but not recruiting. This document serves as a status update rather than rep…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Eye Disease

Drugs mentioned

• Batoclimab (batoclimab)

Snippet

Sponsor: Immunovant Sciences GmbH | Conditions: Thyroid Eye Disease | Phase 3 | Status: ACTIVE_NOT_RECRUITING